References
- Bradford P. Extended-spectrum 13-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933–51.
- Bonnet R. Growing group of extended-spectrum I3-lacta-mases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1–14.
- Bauernfeind A, Grimm H, Schweighart S. A new plas-midic cefotaximase in a clinical isolate of Escherichia coll. Infection 1990; 18: 294–8.
- Radice M, Power P, Di Conca J, Gutkind G. Early dis-semination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 2002; 46: 602–4.
- Yagi T, Kurokawa H, Shibata N, Shibayama K, Arakawa Y. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 2000; 184: 53–6.
- Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum 13-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735–43.
- Pagani L, Dell'Amico E, Migliavacca R, et al. Multiple CTX-M type extended-spectrum 13-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 2003; 41: 4264–9.
- Tassios PT, Gazouli M, Tzelepi E, et al. Spread of Salmonella typhimurium clone rsistant to expanded-spectrum cephalosporins in three European countries. J Clin Microbiol 1999; 37: 3774–7.
- Eisner A, Fagan EJ, Feierl G, et al. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spec-trum beta-lactamase in Austria. Antimicrob Agents Chemother 2006; 50: 791-7.1°
- Touati A, Benallaoua S, Forte D, Madoux J, Brasme L, de Champs C. First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Bejaia, Algeria. J Antimicrob Agents 2006; 27: 408–13.
- Bedenic B, Schmidt H, Herald S, et al. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5beta-lactamase in Dubrava University Hospital, Zagreb, Croatia. J Chemother 2005; 17 (4): 367–75.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically. M7-A6. Wayne (PA): The Committee; 2003.
- Kaufman ME. Pulsed-field gel electrophoresis. In: Woodford N, Johnsons A, ed. Molecular bacteriology. Protocols and clinical applications. New York: Humana Press Inc.1998: 33-51.
- Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-filed gel electrophoresis; criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233–9.
- Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 2nd ed. Baltimore: Williams and Wilkins, 1986; 683–721.
- Brenwald NP, Jevons G, Andrews JM, Xiong JH, Hawkey PM, Wise R. An outbreak of a CTX-M type I3-lacta-mase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum 13-lactamase. J Antimicrob Chemother 2003; 51: 195–6.
- Winstanely TG, Ridgway EJ, Parys BT, Woodford N, Ward E, Livermore DM. First isolation of a CTX-M-3 13-lacta-mase producer in the United Kingdom. Int J Antimicrob Agents 2004; 24: 625–7.